Barbiturates Uses Effects and Risks

  • Aug 8th 2025
  • Est. 7 minutes read

Barbiturates are sedative-hypnotic medications known for their powerful ability to ease pain, induce sleep, and calm intense anxiety. Once hailed as miracle treatments, these medications found their way into countless medicine cabinets and emergency rooms. However, thanks to new alternatives with fewer side effects, their use has become less common in recent years. Nevertheless, barbiturates still spark curiosity and concern, raising important questions about their uses, effects, and risks for those who encounter them.

What are Barbiturates?

Developed in the early 20th century, barbiturates were initially celebrated as a medical breakthrough for treating conditions like anxiety, insomnia, and seizure disorders. Working to increase the neurotransmitter gamma-aminobutyric acid (GABA), barbiturates intensify the brain’s natural ability to dampen nerve activity. This results in effects ranging from mild relaxation to deep anesthesia, depending on the dose. Given their predictable ability to calm the nervous system quickly, they became a standard prescription for a variety of health concerns [1]

Fast forward to today, and barbiturates’ risks, including the potential for misuse, dependence, and accidental overdose, have become apparent. In fact, the U.S. Drug Enforcement Administration (DEA) now classifies various barbiturates as Schedule II, III, or IV controlled substances, based on their medical value and potential for abuse. These classifications generally mean that while barbiturates have accepted medical uses, they require strict oversight and careful prescription practices [2].   

While the U.S. Food and Drug Administration (FDA) still approves the use of barbiturates for some indications, barbiturates have mostly been replaced by other substances (e.g., benzodiazepines for sleep and anxiety disorders as well as propofol for anesthetic purposes) [3]. Thus, the story of barbiturates reflects a journey from medical innovation to caution, reminding both patients and professionals of the need for vigilance with these powerful medications.

Barbiturate Types and Uses

When barbiturates played a central role in medical treatment, doctors prescribed them to manage anxiety, provide sedation before medical procedures, treat seizure disorders, manage neonatal withdrawal, and treat increased intracranial pressure (ICP) (a life-threatening imbalance of brain fluid and blood often caused by traumatic brain injury). Their fast-acting, calming effects made them a mainstay in hospital settings, helping patients relax or sleep when rest was desperately needed [3]

While newer drugs have largely taken the place of barbiturates, they’re still used for some conditions. FDA-approved barbiturates include [3]:

  • Amobarbital: While amobarbital is approved for insomnia, its use is not endorsed by the American Association of Sleep Medicine.
  • Butalbital: Primarily used for treating headache disorders, butalbital is available in combinations (e.g., with acetaminophen or aspirin) for tension headaches.
  • Methohexital: Methohexital provides short-duration sedation for certain minor surgeries. 
  • Pentobarbital: Employed as a pre-anesthetic for prolonged or repetitive seizures, pentobarbital is also used off-label to manage ICP.
  • Phenobarbital: This versatile barbiturate is primarily used to prevent seizures in newborns and children. It’s also effective for treating persistent seizures.
  • Primidone: Primidone is primarily prescribed for seizure disorders and tremors.

Despite FDA approvals, barbiturates still present a risk when misused outside their intended medical purposes. Thus, careful management and consideration are paramount.

Barbiturate Risks 

As science has progressed, the risks and side effects of barbiturate use have become more apparent. Several barbiturates now carry risk-related boxed warnings, the FDA’s strongest safety alert. Among them, methohexital poses risks of airway obstruction, vocal cord spasms that affect breathing, and respiratory depression. Meanwhile, phenobarbital warnings highlight the potential for fetal harm when used during pregnancy [3]

As a general drug class, barbiturates can also lower normal heart and breathing rates. As such, heightened doses of barbiturates can cause respiratory distress, which can be life-threatening. Additionally, due to their impact on the liver, barbiturates interact with several other medications, potentially making them less effective when taken alongside barbiturates. What’s more, pregnant or breastfeeding women face additional risks, as barbiturates can disrupt fetal development and can pass through breast milk to children [4]

Risk of Misuse and Addiction

People sometimes take barbiturates outside of prescribed guidelines, either in higher doses or for more extended periods, in search of their sedating or euphoric effects. This pattern of misuse can quickly lead to tolerance and, ultimately, to physical dependence and addiction [5]. In clinical terms, this type of substance use disorder falls under what is known as a sedative, hypnotic, or anxiolytic use disorder [6]

To better understand the degree of misuse, it helps to consider data from the 2023 National Survey on Drug Use and Health (NSDUH), which categorizes barbiturates as prescription sedatives. According to the 2023 NSDUH, roughly 4.7 million people aged 12 and older (1.7%) reported misusing prescription tranquilizers or sedatives in the past year [7]

Unfortunately, the consequences of barbiturate misuse can be severe. As tolerance develops, people may increase their dosage to achieve the same effects, potentially leading to dependence, withdrawal, and overdose. 

Barbiturate Withdrawal and Overdose

Substance misuse and addiction are closely linked to barbiturate withdrawal, which is the body’s response to suddenly stopping or sharply reducing use after developing physical barbiturate dependence. Withdrawal symptoms for sedative-hypnotic substances such as barbiturates include [6]:

  • Hyperactive nervous system (e.g., elevated pulse rate, sweating)
  • Hand tremors
  • Incomnia
  • Nausea or vomiting
  • Anxiety
  • Seizures
  • Hallucinations

Because withdrawal from barbiturates can be unpredictable, medical supervision is essential for anyone attempting to stop these medications.

The risk of overdose is another serious concern associated with barbiturate use. An overdose occurs when someone takes a dose high enough to dangerously suppress the central nervous system, which can lead to slowed or stopped breathing, unconsciousness, coma, or death. Even a slight increase in dose can have devastating consequences, especially when barbiturates are combined with other depressants like alcohol [5].

Signs of barbiturate intoxication and overdose can include [5]

  • Confusion, faulty judgment
  • Altered level of consciousness
  • Drowsiness, sluggishness, coma
  • Lack of coordination
  • Shallow breathing
  • Slow, slurred speech
  • Staggering, loss of balance

If overdose is suspected, the Centers for Disease Control and Prevention (CDC) recommends the following steps [8]

  • Administer an overdose reversal medication like naloxone (if available) and call 911.
  • Try to keep the person awake and breathing.
  • Lay the person on their side to prevent choking.
  • Stay with the person until emergency assistance arrives.

Prompt emergency intervention is critical, as an overdose can have life-threatening outcomes.

Treatment for Barbiturate Addiction

Mental health recovery from barbiturate addiction typically begins with withdrawal and detoxification. Because withdrawal from barbiturates can be severe, medically monitored detox is highly recommended [3]. Within a professional detox setting, medical professionals closely monitor and manage withdrawal symptoms, ensuring patient safety. 

Detox in itself, however, is a small part of an effective treatment program. Thus, most people progress from detox to one of the following addiction-treatment programs: 

  • Inpatient or Residential Treatment: This type of care provides 24/7 support within a highly structured, live-in setting. It focuses on immediate stabilization and offers continuous access to medical and psychiatric professionals.
  • Partial Hospitalization Program (PHP): A PHP is a step down in intensity from inpatient care. Participants attend daily treatment sessions several times a week and return home in the evenings, allowing for intensive therapy and medication management without requiring full hospitalization.
  • Intensive Outpatient Program (IOP): IOPs offer a supportive and flexible environment for people needing more than weekly therapy but less than daily supervision. These programs generally convene three to five times a week, emphasizing group therapy, coping strategies, and relapse prevention.
  • Outpatient Treatment: Outpatient care consists of regular sessions with a therapist, psychiatrist, or treatment team. It’s often used for ongoing maintenance or medication management, or as a follow-up after a more intensive treatment program.

Whether treatment takes place in a hospital, clinic, or community setting, hope and healing are possible. With the proper support and a personalized plan, recovery from barbiturate addiction is within reach.

Looking Forward

Barbiturates represent both the progress and challenges of modern medicine. While barbiturates once stood at the forefront of medical treatment, their risks, including the potential for dependence and addiction, prompted a shift toward safer alternatives. 

Today, their story serves as a poignant reminder of how far medicine has come in prioritizing patient safety and well-being. Being informed about the uses, effects, and potential dangers of barbiturates enables people to make informed decisions about their health.

Although addiction remains a possibility, the real focus is on prevention, open communication, and choosing safer therapies whenever possible. By partnering with healthcare providers and staying alert to risks, everyone can take proactive steps toward healthier, more secure outcomes.

References
  1. Suddock JT, Kent KJ, Regina AC, et al. Barbiturate Toxicity. [Updated 2024 Feb 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499875
  2. Department of Justice/Drug Enforcement Administration. (2024, December). Barbiturates. Department of Justice/Drug Enforcement Administration . https://www.dea.gov/sites/default/files/2025-01/Barbiturates-2024-Drug-Fact-Sheet.pdf 
  3. Skibiski J, Patel P, Abdijadid S. Barbiturates. [Updated 2024 Jan 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK539731
  4. Cleveland Clinic. (2022, June 14). Barbiturates. Cleveland Clinic. https://my.clevelandclinic.org/health/treatments/23271-barbiturates
  5. MedlinePlus. (2023, July 1). Barbiturate intoxication and overdose. National Library of Medicine.  https://medlineplus.gov/ency/article/000951.htm
  6. American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed. text rev.). https://www.psychiatry.org/psychiatrists/practice/dsm
  7. Substance Abuse and Mental Health Services Administration. (2024). Key Substance Use and Mental Health Indicators in the United States: Results from the 2023 National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/data/sites/default/files/reports/rpt47095/National%20Report/National%20Report/2023-nsduh-annual-national.pdf
  8. Centers for Disease Control and Prevention. (2024, April 2). What to do if you think someone is overdosing. Centers for Disease Control and Prevention. https://www.cdc.gov/stop-overdose/response/index.html
Author Linda Armstrong Writer

Linda Armstrong is an award-winning writer and editor with over 20 years of experience across print and digital media.

Published: Aug 8th 2025, Last updated: Aug 25th 2025

Medical Reviewer Dr. Shivani Kharod, Ph.D. Ph.D.

Dr. Shivani Kharod, Ph.D. is a medical reviewer with over 10 years of experience in delivering scientifically accurate health content.

Content reviewed by a medical professional. Last reviewed: Aug 8th 2025
Medical Content

The Clinical Affairs Team at MentalHealth.com is a dedicated group of medical professionals with diverse and extensive clinical experience. They actively contribute to the development of content, products, and services, and meticulously review all medical material before publication to ensure accuracy and alignment with current research and conversations in mental health. For more information, please visit the Editorial Policy.

About MentalHealth.com

MentalHealth.com is a health technology company guiding people towards self-understanding and connection. The platform provides reliable resources, accessible services, and nurturing communities. Its purpose is to educate, support, and empower people in their pursuit of well-being.